A5046413977- Venous Thromboembolism Diagnosis and Management
- Central Venous Catheters and Hemodialysis
- Atrial Fibrillation Management and Outcomes
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Ischemic Stroke Management
- Platelet Disorders and Treatments
- Immune Cell Function and Interaction
- Lymphoma Diagnosis and Treatment
- Heparin-Induced Thrombocytopenia and Thrombosis
- Blood groups and transfusion
- Cancer Immunotherapy and Biomarkers
- Complement system in diseases
- Hemoglobinopathies and Related Disorders
- Parvovirus B19 Infection Studies
- Cancer, Lipids, and Metabolism
- Acute Myeloid Leukemia Research
- Blood disorders and treatments
- Diagnosis and Treatment of Venous Diseases
- Cancer Treatment and Pharmacology
- Blood Coagulation and Thrombosis Mechanisms
- Autoimmune and Inflammatory Disorders Research
- Eosinophilic Disorders and Syndromes
- Folate and B Vitamins Research
- Blood transfusion and management
The University of Texas MD Anderson Cancer Center
2016-2025
Target (United States)
2022
Tecnológico de Monterrey
2021
Texas Diabetes Institute
2021
The University of Texas Health Science Center at Houston
2018
University of New Mexico
2013-2017
UNM Comprehensive Cancer Center
2013
New Mexico Cancer Center
2013
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common life-threatening condition cancer, its management often requires multidisciplinary efforts. panel comprised specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, pharmacology. content featured this issue...
Chronic Epstein Barr virus (EBV) infection in an immunocompetent host has been described however it is not a common entity. It linked to many lymphoproliferative disorders and achieves such via molecular mechanisms, some of which are poorly understood. In addition infectious mononucleosis, the EBV various other hematological pathologies autoimmune disorders.We describe case elderly female who presented with non-specific symptomatology, lymphadenopathy, cytopenias, elevated autoantibody...
Venous thromboembolism (VTE) is a major contributor to the mortality of cancer patients. Mechanical thrombectomy (MT) an endovascular technique that physically removes thrombus without thrombolytics. The purpose this study was evaluate safety, efficacy, and clinical outcomes following MT for lower extremity DVT in
Recent advancements in immunotherapy have brought promising drugs to fight cancers; a subset of medications are known as checkpoint inhibitors. Their mechanism action relies on upregulating antitumor response by reversing T-cell suppression; consequence the effect can also result spectrum immune related complications. Reported complications date include: skin, gastrointestinal mucosa, hypophysis, liver, endocrine system, nervous kidney, musculoskeletal system and hematologic system. The...
Abstract Lessons Learned There continues to be a lack of systemic options for advanced hepatocellular carcinoma (HCC); sorafenib and, very recently, regorafenib are the only approved options. exists potential combine with chemotherapeutic agents shown active in HCC, such as capecitabine, safely. Good tumor response was observed, objective improvement few patients seldom seen by single agent sorafenib; however, because limited number patients, meaningful conclusions on survival cannot drawn....
Key Points Cold agglutinin syndrome is one of the rare immune-related adverse events nivolumab. Rituximab should be considered for treatment nivolumab-induced cold syndrome.